Subscribe to our Telegram channel to get a daily dose of business and lifestyle news from NHA – News Hub Asia!
- Pfizer has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports, two sources with direct knowledge of the matter told Reuters.
- The US company pulled an application last month seeking emergency approval for its product India after the drug regulator declined its request to skip a small local safety trial. That has kept its vaccine, developed with Germany’s BioNTech, out of one of the world’s biggest drug markets.
- Pfizer was the first company to apply for emergency use authorisation in India, proposing to import doses from its US and European facilities instead of producing locally.
- “US companies want to produce vaccines in India under joint ventures,” said one of the sources, citing Pfizer and fellow US drugmaker Moderna.
- Another source confirmed Pfizer was interested in manufacturing in India but Reuters could not find a second confirmation on Moderna.
What is your plan for crisis control? Need help managing your organization crisis? Each crisis is different, if you have a crisis contact us immediately at https://www.crisismanagementcentre.com/contact-us/
We are ready to manage your crisis.